MICHAEL SIMON received the 2015 Blue Cross Blue Shield of Michigan Foundation McDevitt Excellence in Research Award for Physicians in the area of clinical research. Simon is leader of the Breast Cancer Multidisciplinary Team and co-leader of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
